Conclave and Consensus of 11th Diabetes and Pregnancy Study Group India Conference
at Delhi on 21st and 22nd Feb 2016
Prof. S.V. Madhu, Dr. Anil Kapur, Dr. Rajeev Chawla, Prof. Dr. V. Balaji, Dr. Brij Makkar, Dr. Hema Diwakar
Single step testing using 75 g oral glucose & measuring plasma glucose 2 hour after ingestion. 75 g glucose is to be given orally after dissolving in approximately 300 ml water whether the PW (Pregnant Woman) comes in fasting or non-fasting state, irrespective of the last meal. The intake of the solution has to be completed within 5 min. A plasma standardised glucometer should be used to evaluate blood glucose 2 hours after the oral glucose load. If vomiting occurs within 30 min of oral glucose intake, the test has to be repeated the next day, if vomiting occurs after 30 minutes, the test continues.
To Study the Awareness about Gestational Diabetes Mellitus in Females among General Population
Praneet Wander, Vitull K. Gupta, Meghna Gupta, Sonia Arora, Arun Kumar Maria
Socio-economic development and rapid epidemiological transition over the last 40 years in India have resulted in gaining dubious distinction of being called "the diabetic capital of the world” with estimated over 30 million diabetics, where the predicted increase in prevalence is highest. In the presence of paucity of data on gestational diabetes mellitus (GDM) it is reasonable to conclude increased prevalence of GDM in the Indian Population.
Artificial Sweeteners
Dr. Jyoti Bobde
Sweeteners are food substances used to improve the taste and flavor of foods. Major ingredients in natural sweeteners are mono- or disaccharides, thus have nutritional or caloric value.1 Though it is thought that many factors contribute to obesity, high sugar and fat intake are considered as the leading causes. This thinking has resulted in the increase use of non-nutritive sweeteners (NNSs). In 1885 Constant in Fahlberg produced the first artificial sweetner, saccharin which surprised scientific establishment due to its extreme sweetness.
Treatment of Hypertriglyceridemia in a Diabetic Patient with Renal Impairment
Dr. Balaji Jaganmohan
Hypertriglyceridemia is a challenge to treat the renally impaired patients as it has been recorded in several studies that the well-known class of drugs to treat hypertriglyceridemia fibrates tends to increase serum creatinine. In the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial a 12% average creatinine elevation (from 0.88 to 0.99 mg/dL) which was reversible on discontinuation was noted with fenofibrate.
Acute Charcot Foot
Prof. Samar Banerjee
Long back in 1701, William Musgrave for the first time described a neuropathic joint as an arthralgia caused by venereal disease. In 1868, Jean-Martin Charcot gave the first detailed description of the neuoropathic aspect of this disease as a complication of syphilis and named the condition after him. In 1936, Jordan linked it to diabetes and now is considered to be the most common etiology of Charcot arthropathy.
Journal Watch
This consensus critically evaluated the clinical implications of the use of non-fasting rather than fasting lipid profiles and to provide guidance to the laboratory reporting of abnormal non-fasting or fasting lipid profiles. Extensive observational data, in which random non-fasting lipid profile have been compared with those determined under fasting conditions, indicate that the maximal mean changes.
News
The First National Congress on Critical Diabetes was organised by Association Of Clinical Diabetology on 9th and 10th April 2016 at Kolkata. The theme of the conference was translating knowledge into practice. About 450 delegates and 74 faculties exchanged their views. The programme was inaugurated by Swami
Sebabratanada Maharaj of Ramkrishna Mission Seba Pratisthan .The Lifetime Achievement award was offered to Prof V Seshiah (Chennai), Congress oration to Prof Shashank Joshi (Mumbai) and the Young Achiever’s award to Dr. Sunil Gupta (Nagpur) The programme was a grand success.
Quiz
Announcement
